Adverum Biotechnologies, Inc. Separation Agreements
11 Contracts & Agreements
- Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Richard Beckman, M.D., dated as of May 24, 2023 (Filed With SEC on August 10, 2023)
- Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of June 7, 2022 (Filed With SEC on August 11, 2022)
- Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021 (Filed With SEC on November 4, 2021)
- Separation Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021 (Filed With SEC on May 6, 2021)
- Separation Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated April 7, 2021 (Filed With SEC on May 6, 2021)
- Separation Letter, dated May 1, 2019, between Adverum Biotechnologies, Inc. and Paul Cleveland (Filed With SEC on August 8, 2019)
- Athena Countouriotis Separation Agreement (Filed With SEC on November 8, 2018)
- Amber Salzman Separation Agreement (Filed With SEC on November 8, 2018)
- Separation Agreement, entered into September 1, 2017, by and between Adverum Biotechnologies, Inc. and Samuel B. Barone, M.D (Filed With SEC on September 1, 2017)
- SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on March 4, 2016)
- SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on July 23, 2015)
